Robert M. Plenge

Robert M. Plenge

Auto-generated profile, based on publicly available information

Robert M. Plenge

Program in Medical and Population Genetics, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2013 in Nature Reviews Drug Discovery
Verified
Journal Article
Closed access
RPRobert M. Plenge
Robert M. Plenge
ESEdward M. Scolnick
Edward M. Scolnick
DADavid Altshuler
David Altshuler

4 November 2007 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
RPRobert M Plenge
Robert M Plenge
CCChris Cotsapas
Chris Cotsapas
LDLeela Davies
Leela Davies
APAlkes L Price
Alkes L Price
PBPaul I W de Bakker
Paul I W de Bakker
DADavid Altshuler
David Altshuler

14 September 2008 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
SRSoumya Raychaudhuri
Soumya Raychaudhuri
ERElaine F Remmers
Elaine F Remmers
ALAnnette T Lee
Annette T Lee
RHRachel Hackett
Rachel Hackett
CGCandace Guiducci
Candace Guiducci
RPRobert M Plenge
Robert M Plenge

24 February 2011 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
AZAlexandra Zhernakova
Alexandra Zhernakova
ESEli A Stahl
Eli A Stahl
GTGosia Trynka
Gosia Trynka
SRSoumya Raychaudhuri
Soumya Raychaudhuri
EFEleanora A Festen
Eleanora A Festen
RPRobert M Plenge
Robert M Plenge
Epidemiology and candidate gene studies indicate a shared genetic basis for celiac disease (CD) and rheumatoid arthritis (RA), but the extent of this sharing has not been systematically explored. Previous studies demonstrate that 6 of the established non-HLA CD and RA risk loci (out of 26 loci for each disease) are shared between both diseases. We hypothesized that there are additional shared risk alleles and that combining genome-wide association study (GWAS) data from each disease would increase power to identify these shared risk alleles. We performed a meta-analysis of two published GWAS on CD (4,533 cases and 10,750 controls) and RA (5,539 cases and 17,231 controls). After genotyping the top associated SNPs in 2,169 CD cases and 2,255 controls, and 2,845 RA cases and 4,944 controls, 8 additional SNPs demonstrated P<5×10−8 in a combined analysis of all 50,266 samples, including four SNPs that have not been previously confirmed in either disease: rs10892279 near the DDX6 gene (Pcombined = 1.2×10−12), rs864537 near CD247 (Pcombined = 2.2×10−11), rs2298428 near UBE2L3 (Pcombined = 2.5×10−10), and rs11203203 near UBASH3A (Pcombined = 1.1×10−8). We also confirmed that 4 gene loci previously established in either CD or RA are associated with the other autoimmune disease at combined P<5×10−8 (SH2B3, 8q24, STAT4, and TRAF1-C5). From the 14 shared gene loci, 7 SNPs showed a genome-wide significant effect on expression of one or more transcripts in the linkage disequilibrium (LD) block around the SNP. These associations implicate antigen presentation and T-cell activation as a shared mechanism of disease pathogenesis and underscore the utility of cross-disease meta-analysis for identification of genetic risk factors with pleiotropic effects between two clinically distinct diseases. Celiac disease (CD) and rheumatoid arthritis (RA) are two autoimmune diseases characterized by distinct clinical features but increased co-occurrence in families and individuals. Genome-wide association studies (GWAS) performed in CD and RA have identified the HLA region and 26 non-HLA genetic risk loci in each disease. Of the 26 CD and 26 RA risk loci, previous studies have shown that six are shared between the two diseases. In this study we aimed to identify additional shared risk alleles and, in doing so, gain more insight into shared disease pathogenesis. We first empirically investigated the distribution of putative risk alleles from GWAS across both diseases (after removing known risk loci for both diseases). We found that CD risk alleles are non-randomly distributed in the RA GWAS (and vice versa), indicating that CD risk alleles have an increased prior probability of being associated with RA (and vice versa). Next, we performed a GWAS meta-analysis to search for shared risk alleles by combing the RA and CD GWAS, performing both directional and opposite allelic effect analyses, followed by replication testing in independent case-control datasets in both diseases. In addition to the already established six non-HLA shared risk loci, we observed statistically robust associations at eight SNPs, thereby increasing the number of shared non-HLA risk loci to fourteen. Finally, we used gene expression studies and pathway analysis tools to identify the plausible candidate genes in the fourteen associated loci. We observed remarkable overrepresentation of T-cell signaling molecules among the shared genes.

25 March 2012 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
DCDiabetes Genetics Replication and Meta-analysis Consortium
Diabetes Genetics Replication and Meta-analysis Consortium
ESEli A Stahl
Eli A Stahl
MCMyocardial Infarction Genetics Consortium
Myocardial Infarction Genetics Consortium
DWDaniel Wegmann
Daniel Wegmann
GTGosia Trynka
Gosia Trynka
RPRobert M Plenge
Robert M Plenge

3 August 2010 in Arthritis Care & Research
Verified
Journal Article
Open access
PDF file
KLKatherine P. Liao
Katherine P. Liao
TCTianxi Cai
Tianxi Cai
VGVivian Gainer
Vivian Gainer
SGSergey Goryachev
Sergey Goryachev
QZQing Zeng‐Treitler
Qing Zeng‐Treitler
RPRobert M. Plenge
Robert M. Plenge
Objective: Electronic medical records (EMRs) are a rich data source for discovery research but are underutilized due to the difficulty of extracting highly accurate clinical data. We assessed whether a classification algorithm incorporating narrative EMR data (typed physician notes) more accurately classifies subjects with rheumatoid arthritis (RA) compared with an algorithm using codified EMR data alone.Methods: Subjects with ≥1 International Classification of Diseases, Ninth Revision RA code (714.xx) or who had anti–cyclic citrullinated peptide (anti‐CCP) checked in the EMR of 2 large academic centers were included in an “RA Mart” (n = 29,432). For all 29,432 subjects, we extracted narrative (using natural language processing) and codified RA clinical information. In a training set of 96 RA and 404 non‐RA cases from the RA Mart classified by medical record review, we used narrative and codified data to develop classification algorithms using logistic regression. These algorithms were applied to the entire RA Mart. We calculated and compared the positive predictive value (PPV) of these algorithms by reviewing the records of an additional 400 subjects classified as having RA by the algorithms.Results: A complete algorithm (narrative and codified data) classified RA subjects with a significantly higher PPV of 94% than an algorithm with codified data alone (PPV of 88%). Characteristics of the RA cohort identified by the complete algorithm were comparable to existing RA cohorts (80% women, 63% anti‐CCP positive, and 59% positive for erosions).Conclusion: We demonstrate the ability to utilize complete EMR data to define an RA cohort with a PPV of 94%, which was superior to an algorithm using codified data alone.